Stock CYCN CYCLERION THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Cyclerion Therapeutics, Inc.

Equities

CYCN

US23255M2044

Delayed Nasdaq
Other stock markets
 12:08:45 2024-04-29 pm EDT 		5-day change 1st Jan Change
3.08 USD +5.12% Intraday chart for Cyclerion Therapeutics, Inc. +0.98% -8.06%
Mar. 05 Cyclerion Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Cyclerion Therapeutics, Inc. Appoints Regina Graul as President CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CYCLERION THERAPEUTICS : Truist Securities Starts Cyclerion Therapeutics at Buy with $14 Price Target
MT
CYCLERION THERAPEUTICS : Cantor Fitzgerald Starts Cyclerion Therapeutics at Overweight with $7 Price Target
MT
CYCLERION THERAPEUTICS : Cantor Fitzgerald Initiates Cyclerion Therapeutics at Overweight Rating With $7 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CYCN Stock
  4. News Cyclerion Therapeutics, Inc.
  5. Analyst Reco.